RICCERI, FEDERICA
RICCERI, FEDERICA
Scienze della Salute (DSS)
Age affects drug survival rates of interleukin (IL)‐17 and IL‐23 inhibitors in patients with plaque psoriasis: Results from a retrospective, multicentric, multi‐country, cohort study
2024 Chiricozzi, Andrea; Coscarella, Giulia; Puig, Luis; Vender, Ron; Yeung, Jensen; Carrascosa, José‐Manuel; Piaserico, Stefano; Gisondi, Paolo; Lynde, Charles; Ferreira, Paulo; Bastos, Pedro Mendes; Dauden, Esteban; Leite, Luiz; Valerio, Joana; del Alcázar‐Viladomiu, Elena; Vilarrasa, Eva; Llamas‐Velasco, Mar; Alessandri‐Bonetti, Mario; Messina, Francesco; Bruni, Manfredo; Di Brizzi, Eugenia Veronica; Ricceri, Federica; Nidegger, Alessia; Hugo, Jan; Mufti, Asfandyar; Daponte, Athina‐Ioanna; Teixeira, Laetitia; Balato, Anna; Romanelli, Marco; Prignano, Francesca; Gkalpakiotis, Spyridon; Conrad, Curdin; Lazaridou, Elizabeth; Rompoti, Natalia; Stratigos, Alexander J.; Nogueira, Miguel; Peris, Ketty; Torres, Tiago
Atopic dermatitis.
2008 G. Buggiani;F. Ricceri;T. Lotti
Clindamycin as unique antibiotic choice in Hidradenitis Suppurativa
2019 Rosi E, Pescitelli L, Ricceri F, Di Cesare A, Novelli A, Pimpinelli N, Prignano F.
Comparison of body weight and clinical-parameter changes following the treatment of plaque psoriasis with biological therapies.
2009 F. Prignano;F. Ricceri;L. Pescitelli;G. Buggiani;M. Troiano;F. Zanieri;S. Rossari;T. Lotti
Development of monoclonal gammopathy in 12 patients receiving efalizumab treatment for chronic plaque psoriasis
2010 Prignano, Francesca; Pescitelli, Leonardo; Ricceri, Federica; Ermini, Angela; Lotti, Torello
Drug Survival of Interleukin (IL)‑17 and IL‑23 Inhibitors for the Treatment of Psoriasis: A Retrospective Multi‑country, Multicentric Cohort Study
2022 Torres, Tiago; Puig, Luis; Vender, Ron; Yeung, Jensen; Carrascosa, José-Manuel; Piaserico, Stefano; Gisondi, Paolo; Lynde, Charles; Ferreira, Paulo; Bastos, Pedro Mendes; Dauden, Esteban; Leite, Luiz; Valerio, Joana; del Alcázar-Viladomiu, Elena; Rull, Eva Vilarrasa; Llamas-Velasco, Mar; Pirro, Federico; Messina, Francesco; Bruni, Manfredo; Licata, Gaetano; Ricceri, Federica; Nidegger, Alessia; Hugo, Jan; Mufti, Asfandyar; Daponte, Athina-Ioanna; Teixeira, Laetitia; Balato, Anna; Romanelli, Marco; Prignano, Francesca; Gkalpakiotis, Spyridon; Conrad, Curdin; Lazaridou, Elizabeth; Rompoti, Natalia; Papoutsaki, Marina; Nogueira, Miguel; Chiricozzi, Andrea
Efficacy of risankizumab after intra-class switching between anti IL-23 antagonists: a multi-center, retrospective, real-life observation
2024 MANZO MARGIOTTA, Flavia; MICHELUCCI, Alessandra; CAPALBO, Eugenio; RICCERI, Federica; ROSI, Elia; ROSSARI, Susanna; MAGNANO, Michela; SAVARESE, Imma; MILANESI, Nicola; SIMONI, Barbara; ROMANELLI, Marco; RUBEGNI, Pietro; DI CESARE, Antonella; PANDURI, Salvatore; PESCITELLI, Leonardo; TROVATO, Emanuele; PRIGNANO, Francesca
Etanercept restores a differentiated keratinocyte phenotype in psoriatic human skin: a morphological study
2012 Donetti, Elena; Gualerzi, Alice; Ricceri, Federica; Pescitelli, Leonardo; Bedoni, Marzia; Prignano, Francesca
Etanercept therapy in a hepatitis B virus (HBV)‐positive psoriatic patient developing a monoclonal gammopathy of undetermined significance
2011 Prignano, Francesca; Ricceri, Federica; Pescitelli, Leonardo; Bonciani, Diletta; Lotti, Torello
Gottron papules: a pathognomonic sign of dermatomyositis
2013 Ricceri, Federica; Prignano, Francesca
Hidradenitis Suppurativa: The Influence of Gender, the Importance of Trigger Factors and the Implications for Patient Habits
2022 Rosi E.; Fastame M.T.; Silvi G.; Guerra P.; Nunziati G.; Di Cesare A.; Scandagli I.; Ricceri F.; Prignano F.
Induction of apoptosis by fractional CO 2 laser treatment
2012 Prignano, Francesca; Ricceri, Federica; Bonan, Paolo; Cannarozzo, Giovanni; Campolmi, Piero
Long-term safety and efficacy of anti-tumor necrosis factor-alpha biosimilar agents in the treatment of psoriasis: a single center study
2022 Ricceri, Federica; Rosi, Elia; Di Cesare, Antonella; Scandagli, Ilaria; Fastame, Maria Thais; Prignano, Francesca
NADPH Oxidase 4 as a Source of Oxidative Stress in Fibroblasts From Patients Affected by Psoriasis
2011 F. Prignano;V. Barygina;M. Becatti;L. Pescitelli;F. Ricceri;S. Agrippino;T. Lotti;N. Taddei
Photodynamic treatment for viral infections of the skin.
2009 R. Rossi;N. Bruscino;F. Ricceri;M. Grazzini;M. Dindelli;T. Lotti
Psoriasis and body mass index.
2010 J. Hercogová;F. Ricceri;L. Tripo;T. Lotti;F. Prignano
Quantity, distribution and immunophenotypical modification of dendritic cells upon biological treatments in psoriasis.
2009 F. Prignano;F. Ricceri;B. Bianchi;T. Lotti
Real‐life effectiveness of Risankizumab according to body mass index: Results of an Italian multicentre retrospective study
2023 Dragotto, Martina; Capalbo, Eugenio; Cartocci, Alessandra; Manzo Margiotta, Flavia; Michelucci, Alessandra, Rosi Elia, Ricceri Federica, Simoni, Barbara; Savarese, Imma; Milanesi, Nicola; Rossari, Susanna; Magnano, Michela; Romanelli, Marco; Rubegni, Pietro, Prignano Francesca, Di Cesare Antonella, Panduri, Salvatore; Pescitelli, Leonardo; Trovato, Emanuele
Reply
2011 Prignano, Francesca; Pescitelli, Leonardo; Ricceri, Federica; Ermini, Angela; Lotti, Torello
Retrospective analysis of systemic treatments for psoriasis patients attending a Psocare center in Florence. Relevance of biological drugs use and comorbidities.
2009 F. Prignano;L. Pescitelli;F. Ricceri;T. Lotti
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Age affects drug survival rates of interleukin (IL)‐17 and IL‐23 inhibitors in patients with plaque psoriasis: Results from a retrospective, multicentric, multi‐country, cohort study | 2024 | Chiricozzi, Andrea; Coscarella, Giulia; Puig, Luis; Vender, Ron; Yeung, Jensen; Carrascosa, José‐Manuel; Piaserico, Stefano; Gisondi, Paolo; Lynde, Charles; Ferreira, Paulo; Bastos, Pedro Mendes; Dauden, Esteban; Leite, Luiz; Valerio, Joana; del Alcázar‐Viladomiu, Elena; Vilarrasa, Eva; Llamas‐Velasco, Mar; Alessandri‐Bonetti, Mario; Messina, Francesco; Bruni, Manfredo; Di Brizzi, Eugenia Veronica; Ricceri, Federica; Nidegger, Alessia; Hugo, Jan; Mufti, Asfandyar; Daponte, Athina‐Ioanna; Teixeira, Laetitia; Balato, Anna; Romanelli, Marco; Prignano, Francesca; Gkalpakiotis, Spyridon; Conrad, Curdin; Lazaridou, Elizabeth; Rompoti, Natalia; Stratigos, Alexander J.; Nogueira, Miguel; Peris, Ketty; Torres, Tiago | |
| Atopic dermatitis. | 2008 | G. Buggiani;F. Ricceri;T. Lotti | |
| Clindamycin as unique antibiotic choice in Hidradenitis Suppurativa | 2019 | Rosi E, Pescitelli L, Ricceri F, Di Cesare A, Novelli A, Pimpinelli N, Prignano F. | |
| Comparison of body weight and clinical-parameter changes following the treatment of plaque psoriasis with biological therapies. | 2009 | F. Prignano;F. Ricceri;L. Pescitelli;G. Buggiani;M. Troiano;F. Zanieri;S. Rossari;T. Lotti | |
| Development of monoclonal gammopathy in 12 patients receiving efalizumab treatment for chronic plaque psoriasis | 2010 | Prignano, Francesca; Pescitelli, Leonardo; Ricceri, Federica; Ermini, Angela; Lotti, Torello | |
| Drug Survival of Interleukin (IL)‑17 and IL‑23 Inhibitors for the Treatment of Psoriasis: A Retrospective Multi‑country, Multicentric Cohort Study | 2022 | Torres, Tiago; Puig, Luis; Vender, Ron; Yeung, Jensen; Carrascosa, José-Manuel; Piaserico, Stefano; Gisondi, Paolo; Lynde, Charles; Ferreira, Paulo; Bastos, Pedro Mendes; Dauden, Esteban; Leite, Luiz; Valerio, Joana; del Alcázar-Viladomiu, Elena; Rull, Eva Vilarrasa; Llamas-Velasco, Mar; Pirro, Federico; Messina, Francesco; Bruni, Manfredo; Licata, Gaetano; Ricceri, Federica; Nidegger, Alessia; Hugo, Jan; Mufti, Asfandyar; Daponte, Athina-Ioanna; Teixeira, Laetitia; Balato, Anna; Romanelli, Marco; Prignano, Francesca; Gkalpakiotis, Spyridon; Conrad, Curdin; Lazaridou, Elizabeth; Rompoti, Natalia; Papoutsaki, Marina; Nogueira, Miguel; Chiricozzi, Andrea | |
| Efficacy of risankizumab after intra-class switching between anti IL-23 antagonists: a multi-center, retrospective, real-life observation | 2024 | MANZO MARGIOTTA, Flavia; MICHELUCCI, Alessandra; CAPALBO, Eugenio; RICCERI, Federica; ROSI, Elia; ROSSARI, Susanna; MAGNANO, Michela; SAVARESE, Imma; MILANESI, Nicola; SIMONI, Barbara; ROMANELLI, Marco; RUBEGNI, Pietro; DI CESARE, Antonella; PANDURI, Salvatore; PESCITELLI, Leonardo; TROVATO, Emanuele; PRIGNANO, Francesca | |
| Etanercept restores a differentiated keratinocyte phenotype in psoriatic human skin: a morphological study | 2012 | Donetti, Elena; Gualerzi, Alice; Ricceri, Federica; Pescitelli, Leonardo; Bedoni, Marzia; Prignano, Francesca | |
| Etanercept therapy in a hepatitis B virus (HBV)‐positive psoriatic patient developing a monoclonal gammopathy of undetermined significance | 2011 | Prignano, Francesca; Ricceri, Federica; Pescitelli, Leonardo; Bonciani, Diletta; Lotti, Torello | |
| Gottron papules: a pathognomonic sign of dermatomyositis | 2013 | Ricceri, Federica; Prignano, Francesca | |
| Hidradenitis Suppurativa: The Influence of Gender, the Importance of Trigger Factors and the Implications for Patient Habits | 2022 | Rosi E.; Fastame M.T.; Silvi G.; Guerra P.; Nunziati G.; Di Cesare A.; Scandagli I.; Ricceri F.; Prignano F. | |
| Induction of apoptosis by fractional CO 2 laser treatment | 2012 | Prignano, Francesca; Ricceri, Federica; Bonan, Paolo; Cannarozzo, Giovanni; Campolmi, Piero | |
| Long-term safety and efficacy of anti-tumor necrosis factor-alpha biosimilar agents in the treatment of psoriasis: a single center study | 2022 | Ricceri, Federica; Rosi, Elia; Di Cesare, Antonella; Scandagli, Ilaria; Fastame, Maria Thais; Prignano, Francesca | |
| NADPH Oxidase 4 as a Source of Oxidative Stress in Fibroblasts From Patients Affected by Psoriasis | 2011 | F. Prignano;V. Barygina;M. Becatti;L. Pescitelli;F. Ricceri;S. Agrippino;T. Lotti;N. Taddei | |
| Photodynamic treatment for viral infections of the skin. | 2009 | R. Rossi;N. Bruscino;F. Ricceri;M. Grazzini;M. Dindelli;T. Lotti | |
| Psoriasis and body mass index. | 2010 | J. Hercogová;F. Ricceri;L. Tripo;T. Lotti;F. Prignano | |
| Quantity, distribution and immunophenotypical modification of dendritic cells upon biological treatments in psoriasis. | 2009 | F. Prignano;F. Ricceri;B. Bianchi;T. Lotti | |
| Real‐life effectiveness of Risankizumab according to body mass index: Results of an Italian multicentre retrospective study | 2023 | Dragotto, Martina; Capalbo, Eugenio; Cartocci, Alessandra; Manzo Margiotta, Flavia; Michelucci, Alessandra, Rosi Elia, Ricceri Federica, Simoni, Barbara; Savarese, Imma; Milanesi, Nicola; Rossari, Susanna; Magnano, Michela; Romanelli, Marco; Rubegni, Pietro, Prignano Francesca, Di Cesare Antonella, Panduri, Salvatore; Pescitelli, Leonardo; Trovato, Emanuele | |
| Reply | 2011 | Prignano, Francesca; Pescitelli, Leonardo; Ricceri, Federica; Ermini, Angela; Lotti, Torello | |
| Retrospective analysis of systemic treatments for psoriasis patients attending a Psocare center in Florence. Relevance of biological drugs use and comorbidities. | 2009 | F. Prignano;L. Pescitelli;F. Ricceri;T. Lotti |